These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12757726)

  • 1. Solid-phase synthesis of a pepticinnamin E library.
    Thutewohl M; Waldmann H
    Bioorg Med Chem; 2003 Jun; 11(12):2591-615. PubMed ID: 12757726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of mono- and bisubstrate inhibitors of protein farnesyltransferase and inducers of apoptosis from a pepticinnamin E library.
    Thutewohl M; Kissau L; Popkirova B; Karaguni IM; Nowak T; Bate M; Kuhlmann J; Müller O; Waldmann H
    Bioorg Med Chem; 2003 Jun; 11(12):2617-26. PubMed ID: 12757727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid-phase synthesis and biological evaluation of a pepticinnamin E library.
    Thutewohl M; Kissau L; Popkirova B; Karaguni IM; Nowak T; Bate M; Kuhlmann J; Müller O; Waldmann H
    Angew Chem Int Ed Engl; 2002 Oct; 41(19):3616-20; 3516. PubMed ID: 12370908
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of tripeptidyl farnesyltransferase inhibitors.
    Lee HY; Sohn JH; Kwon BM
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1599-602. PubMed ID: 12039571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing the hydrophobic pocket of farnesyltransferase: aromatic substitution of CAAX peptidomimetics leads to highly potent inhibitors.
    Qian Y; Marugan JJ; Fossum RD; Vogt A; Sebti SM; Hamilton AD
    Bioorg Med Chem; 1999 Dec; 7(12):3011-24. PubMed ID: 10658608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-thiol farnesyltransferase inhibitors: utilization of an aryl binding site by 5-arylacryloylaminobenzophenones.
    Mitsch A; Böhm M; Wissner P; Sattler I; Schlitzer M
    Bioorg Med Chem; 2002 Aug; 10(8):2657-62. PubMed ID: 12057654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and early structure-activity relationship of farnesyltransferase inhibitors which mimic both the peptidic and the prenylic substrate.
    Schlitzer M; Böhm M; Sattler I; Dahse HM
    Bioorg Med Chem; 2000 Aug; 8(8):1991-2006. PubMed ID: 11003144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and characterization of peptide-based rab geranylgeranyl transferase inhibitors.
    Tan KT; Guiu-Rozas E; Bon RS; Guo Z; Delon C; Wetzel S; Arndt S; Alexandrov K; Waldmann H; Goody RS; Wu YW; Blankenfeldt W
    J Med Chem; 2009 Dec; 52(24):8025-37. PubMed ID: 19894725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-thiol farnesyltransferase inhibitors: the concept of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
    Schlitzer M; Sattler I
    Eur J Med Chem; 2000; 35(7-8):721-6. PubMed ID: 10960188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Farnesyltransferase inhibitors: a new class of cancer chemotherapeutics.
    Koblan KS; Kohl NE; Omer CA; Anthony NJ; Conner MW; deSolms SJ; Williams TM; Graham SL; Hartman GD; Oliff A; Gibbs JB
    Biochem Soc Trans; 1996 Aug; 24(3):688-92. PubMed ID: 8878827
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-thiol farnesyltransferase inhibitors: structure-activity relationships of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
    Schlitzer M; Böhm M; Sattler I
    Bioorg Med Chem; 2002 Mar; 10(3):615-20. PubMed ID: 11814849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-thiol farnesyltransferase inhibitors: FTase-inhibition and cellular activity of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
    Mitsch A; Bergemann S; Gust R; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2003 Jul; 336(4-5):242-50. PubMed ID: 12916059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of a novel series of farnesyl protein transferase inhibitors as non-peptidic CAAX tetrapeptide analogues.
    Perez M; Maraval C; Dumond S; Lamothe M; Schambel P; Etiévant C; Hill B
    Bioorg Med Chem Lett; 2003 Apr; 13(8):1455-8. PubMed ID: 12668011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-peptidic, non-prenylic bisubstrate farnesyltransferase inhibitors. Part 3: structural requirements of the central moiety for farnesyltransferase inhibitory activity.
    Schlitzer M; Böhm M; Sattler I
    Bioorg Med Chem; 2000 Oct; 8(10):2399-406. PubMed ID: 11058034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UCF116, new inhibitors of farnesyltransferase produced by Streptomyces.
    Hara M; Soga S; Itoh M; Shono K; Eishima J; Mizukami T
    J Antibiot (Tokyo); 2000 Jul; 53(7):720-3. PubMed ID: 10994815
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibitors of farnesyltransferase and Ras processing peptidase.
    Hall CC; Watkins JD; Ferguson SB; Foley LH; Georgopapadakou NH
    Biochem Biophys Res Commun; 1995 Dec; 217(3):728-32. PubMed ID: 8554591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and structure-activity relationships of novel piperidine inhibitors of farnesyltransferase.
    Nara S; Tanaka R; Eishima J; Hara M; Takahashi Y; Otaki S; Foglesong RJ; Hughes PF; Turkington S; Kanda Y
    J Med Chem; 2003 Jun; 46(12):2467-73. PubMed ID: 12773050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diastereoselective syntheses of new analogues of the farnesyltransferase inhibitor RPR 130401.
    Pichon N; Harrison-Marchand A; Mailliet P; Maddaluno J
    J Org Chem; 2004 Oct; 69(21):7220-7. PubMed ID: 15471472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From peptide libraries to optimized nonpeptide ligands in the search for S-farnesyltransferase inhibitors.
    Henlin JM; Boutin JA; Kucharczyk N; Desmet-Beaufort C; Loynel A; Bertrand M; Genton A; Tucker GC; Atassi G; Fauchére JL
    J Pept Res; 2001 Feb; 57(2):85-96. PubMed ID: 11168892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different amino acid replacements in CAAX-tetrapeptide based peptidomimetic farnesyltransferase inhibitors.
    Schlitzer M; Sattler I; Dahse HM
    Arch Pharm (Weinheim); 1999 Apr; 332(4):124-32. PubMed ID: 10327885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.